These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1725226)

  • 1. Comparison of the effects of sodium pentosanpolysulfate and unfractionated heparin on venous thrombosis; an experimental study in rats.
    Kiesel J; Harbauer G; Wenzel E; Pindur G; Bohnerth S
    Thromb Res; 1991 Nov; 64(3):301-8. PubMed ID: 1725226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between heparin and a heparin analogue (sodium pentosan polysulphate) in the initial treatment of deep vein thrombosis. Preliminary communication.
    Bergqvist D; Falke P; Jaroszewski H; Lamme S
    Vasa; 1986; 15(1):77-80. PubMed ID: 2421498
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant and antithrombotic effects of chemically modified heparins and pentosanpolysulfate.
    Krupinski K; Breddin HK; Casu B
    Haemostasis; 1990; 20(2):81-92. PubMed ID: 1693353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of biological activities of heparin and fraxiparine induced by the size and the age of a thrombus. Experimental study.
    Doutremepuich C; Llido S; Lalanne MC; Doutremepuich F
    Thromb Res; 1990 Aug; 59(3):439-47. PubMed ID: 2237821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
    Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
    Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of venous thromboses under plaster casts after leg injury. Comparison of heparin-calcium and pentosan sulfuric polyester].
    Normand R; Mathieu JP
    Cah Anesthesiol; 1987 Nov; 35(7):559-62. PubMed ID: 2450622
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model.
    Giedrojć J; Klimiuk M; Radziwon P; Kłoczko J; Bielawiec M; Breddin HK
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):340-5. PubMed ID: 10470990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of heparin, low molecular weight (LMW) heparin, and a heparin analogue on experimental venous thrombosis in the rabbit.
    Björck CG; Bergqvist D; Esquivel C; Nilsson B; Rudsvik Y
    Acta Chir Scand; 1984; 150(8):629-33. PubMed ID: 6085202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug prevention of postoperative deep vein thrombosis. A compararative study of calcium heparinate and sodium pentosan polysulfate.
    Joffe S
    Arch Surg; 1976 Jan; 111(1):37-40. PubMed ID: 1244812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immuno-potent drugs and their association with an unfractionated heparin on an experimental venous thrombosis.
    Puyal C; Lalanne MC; Doutremepuich C
    Thromb Res; 1991 Oct; 64(2):263-72. PubMed ID: 1811344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin, low molecular weight heparin, and heparin analogues.
    Thomas DP
    Br J Haematol; 1984 Nov; 58(3):385-90. PubMed ID: 6208930
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of inhibitors on the thrombogenicity and toxicity of prothrombin complex concentrates.
    Klöcking HP; Dornheim G; Schulze-Riewald H
    Arch Toxicol Suppl; 1987; 11():313-5. PubMed ID: 2443111
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.
    Doutremepuich C; Bousquet F; Gestreau GL; Toulemonde F; Bayrou B
    Haemostasis; 1987; 17(4):201-5. PubMed ID: 3623263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic effects of heparin and related agents.
    Hladovec J; Kornalík F
    Cor Vasa; 1991; 33(1):68-74. PubMed ID: 1655354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does the pentosan polysulfate-heparin have a thrombolytic action?].
    Pinot JJ; Sampol J
    Presse Med; 1986 Oct; 15(33):1683. PubMed ID: 2431405
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic effect of OP/LMWH by subcutaneous route in rats.
    Fantuz M; Milani R; Andriuoli G; Mastacchi R; Barbanti M
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):328-34. PubMed ID: 3767531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
    ; Büller HR; Gent M; Gallus AS; Ginsberg J; Prins MH; Baildon R
    N Engl J Med; 1997 Sep; 337(10):657-62. PubMed ID: 9280815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
    Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model.
    Doutremepuich C; Toulemonde F; de Seze O; Pereira F; Anne MC; Doutremepuich F
    J Leukoc Biol; 1987 Dec; 42(6):628-31. PubMed ID: 2824648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.